Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Protagonist Therapeutics, Inc (PTGX) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/02/2023 4 Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 12,000 shares @ $0
Paid exercise price by delivering 4,150 shares @ $26.07, valued at $108.2k
06/02/2023 4 PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Gifted 10,000 shares @ $0
Granted 30,000 shares @ $0
Paid exercise price by delivering 12,165 shares @ $26.07, valued at $317.1k
06/02/2023 4 Ali Asif (CFO) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 12,000 shares @ $0
Paid exercise price by delivering 4,150 shares @ $26.07, valued at $108.2k
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/18/2023 4 Giraudo Bryan (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 30,000 options to buy @ $12.17, valued at $365.1k
01/18/2023 4 Williams Lewis T (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 30,000 options to buy @ $12.17, valued at $365.1k
01/18/2023 4 Waddill William D. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 30,000 options to buy @ $12.17, valued at $365.1k
01/18/2023 4 Noonberg Sarah B. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 30,000 options to buy @ $12.17, valued at $365.1k
01/18/2023 4 O'Dowd Sarah A (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 30,000 options to buy @ $12.17, valued at $365.1k
01/18/2023 4 SELICK HAROLD E (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 30,000 options to buy @ $12.17, valued at $365.1k
01/18/2023 4 Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 20,625 shares @ $0
Granted 123,750 options to buy @ $12.17, valued at $1.5M
01/18/2023 4 Ali Asif (CFO) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 10,625 shares @ $0
Granted 63,750 options to buy @ $12.17, valued at $775.8k
01/18/2023 4 MOLINA ARTURO MD (Chief Medical Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 3,125 shares @ $0
Granted 18,750 options to buy @ $12.17, valued at $228.2k
01/18/2023 4 PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Gifted 3,000 shares @ $0
Gifted 3,116 shares @ $0
Granted 600,000 options to buy @ $12.17, valued at $7.3M
11/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/17/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
08/24/2022 4 PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Exercised 20,000 options to buy @ $4.21, valued at $84.2k
05/27/2022 4 Waddill William D. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 20,000 options to buy @ $8.31, valued at $166.2k
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Noonberg Sarah B. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 20,000 options to buy @ $8.31, valued at $166.2k
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Giraudo Bryan (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 20,000 options to buy @ $8.31, valued at $166.2k
05/04/2022 4 Waddill William D. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Exercised 12,000 options to buy @ $8.59, valued at $103.1k
05/04/2022 4 PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Exercised 15,742 options to buy @ $4.21, valued at $66.3k
04/26/2022 4 Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Exercised 40,000 options to buy @ $7.38, valued at $295.2k
04/26/2022 4 PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Exercised 30,000 options to buy @ $4.21, valued at $126.3k
04/19/2022 4 Ali Asif (CFO) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 13,750 shares @ $0
Granted 82,500 options to buy @ $19.19, valued at $1.6M
04/19/2022 3 Ali Asif (CFO) has filed a Form 3 on Protagonist Therapeutics, Inc
04/14/2022 4 PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Exercised 34,087 options to buy @ $1.89, valued at $64.4k
03/02/2022 4 Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Paid exercise price by delivering 649 shares @ $24.28, valued at $15.8k
03/02/2022 4 PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Paid exercise price by delivering 4,648 shares @ $24.28, valued at $112.9k
03/02/2022 4 Liu David Y (Chief Scientific Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Paid exercise price by delivering 2,119 shares @ $24.28, valued at $51.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy